Imaging of thyroid tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice

scientific article

Imaging of thyroid tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P8978DBLP publication IDjournals/bmcmi/ManciniGSLMVCPBS13
P6179Dimensions Publication ID1024456207
P356DOI10.1186/1471-2342-13-31
P932PMC publication ID3848463
P698PubMed publication ID24028408
P5875ResearchGate publication ID274348339

P50authorArturo BrunettiQ45394961
Raffaele LiuzziQ56856579
Adelaide GrecoQ57613439
Gennaro ChiappettaQ89340752
Rosa PasquinelliQ114095731
Marco SalvatoreQ37370172
P2093author name stringGiuliana Salvatore
Marcello Mancini
Gennaro Di Maro
Emilia Vergara
P2860cites workTumoral angiogenesis and breast cancerQ37416806
Angiogenesis and ovarian cancer.Q37602374
Anti-VEGF and beyond: shaping a new generation of anti-angiogenic therapies for cancerQ37923576
Molecular genetics and diagnosis of thyroid cancerQ37924088
Differentiated thyroid cancers: a comprehensive review of novel targeted therapiesQ37988566
Relationship between retention of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeted ultrasonographic contrast agent and the level of VEGFR2 expression in an in vivo breast cancer modelQ39979176
Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effectsQ40024036
Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculatureQ40187867
VEGF-RII influences the prognosis of pancreatic cancerQ40687210
Complete inhibition of goiter in mice requires combined gene therapy modification of angiopoietin, vascular endothelial growth factor, and fibroblast growth factor signalingQ45882684
Morphological ultrasound microimaging of thyroid in living mice.Q45933658
Angiogenesis: noninvasive quantitative assessment with contrast-enhanced functional US in murine modelQ46486160
[Angiogenesis as part of the tumor "ecosystem" and possibilities to influence it]Q52598897
Single nucleotide polymorphisms and mRNA expression of VEGF-A in papillary thyroid carcinoma: potential markers for aggressive phenotypes.Q53116192
[Expression of selected angiogenesis markers and modulators in pre-, peri- and postmenopausal women with ovarian cancer].Q53402982
The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium.Q53403133
Clinical significance of VEGFR-2 and VEGFR-3 expression in ovarian cancer patients.Q54589846
Angiogenesis in Pituitary Adenomas and the Normal Pituitary GlandQ60586407
Expression of vascular endothelial growth factor (VEGF) and VEGF receptor-1 (Flt-1) in Graves disease possibly correlated with increased vascular densityQ73427365
Molecular imaging in drug developmentQ22122025
Targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides.Q22255481
Ultrasound biomicroscopy in small animal research: applications in molecular and preclinical imaging.Q27025201
Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesisQ29620559
Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytesQ30306464
Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3.Q30310994
Detection of individual microbubbles of ultrasound contrast agents: imaging of free-floating and targeted bubblesQ30312185
US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in miceQ30431243
Microbubbles in medical imaging: current applications and future directionsQ30433669
Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55).Q30474689
Contrast-enhanced ultrasound for examining tumor biologyQ30493250
Lessons from mouse models of thyroid cancerQ33819911
Guidelines for the welfare and use of animals in cancer researchQ33903753
Applications for multifrequency ultrasound biomicroscopy in mice from implantation to adulthood.Q34144707
Vascular endothelial growth factor: basic science and clinical progressQ34549887
Rearrangements of NTRK1 gene in papillary thyroid carcinoma.Q35010947
Physiological and pathological angiogenesis in the endocrine systemQ35033876
A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculatureQ35118263
Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapyQ35211646
Angiogenesis in endocrine tumors.Q35564920
Anti-VEGF/VEGFR therapy for cancer: reassessing the targetQ35910772
Molecular ultrasound imaging using a targeted contrast agent for assessing early tumor response to antiangiogenic therapyQ36297117
Angiogenesis--a new target for future therapyQ36424620
Primary pancreatic lymphomasQ36473667
The role of angiogenesis inhibition in the treatment of breast cancerQ36670444
Angiogenic growth factorsQ36682043
VEGF in physiological process and thyroid disease.Q36996830
Endoglin in angiogenesis and vascular diseasesQ37088038
Targeted microbubbles for imaging tumor angiogenesis: assessment of whole-body biodistribution with dynamic micro-PET in mice.Q37133833
alphavbeta3 integrin and angiogenesis: a moody integrin in a changing environment.Q37220625
P275copyright licenseCreative Commons Attribution 2.0 GenericQ19125117
P6216copyright statuscopyrightedQ50423863
P4510describes a project that usesmicrobubbleQ6839290
P921main subjectendotheliumQ111140
microbubbleQ6839290
tumor angiogenesisQ110495869
P304page(s)31
P577publication date2013-09-12
P1433published inBMC Medical ImagingQ15746685
P1476titleImaging of thyroid tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice
P478volume13